Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissions

about

Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissions

Item

http://www.wikidata.org/entity/Q57092078

description

article

@en

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Intelligent Network DisRuption ...... n of hepatitis C transmissions

@en

Intelligent Network DisRuption Analysis

@nl

type

Item

label

Intelligent Network DisRuption ...... n of hepatitis C transmissions

@en

Intelligent Network DisRuption Analysis

@nl

prefLabel

Intelligent Network DisRuption ...... n of hepatitis C transmissions

@en

Intelligent Network DisRuption Analysis

@nl

P1476

Intelligent Network DisRuption ...... n of hepatitis C transmissions

@en

P2093

Yury Khudyakov

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of hepatitis C virus infection

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs

Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain

Precision Public Health for the Era of Precision Medicine

Social and Genetic Networks of HIV-1 Transmission in New York City

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

The global transmission network of HIV-1

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection

Efficient detection of viral transmissions with Next-Generation Sequencing data.

Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response.

P304

204-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MEEGID.2018.05.028

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

David S. Campo

P577

2018-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29860098

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

molecular biology

P932

6103852

http://www.w3.org/2001/XMLSchema#string